Veronica Escamilla1, Carla J Chibwesha, Matthew Gartland, Namwinga Chintu, Mwangelwa Mubiana-Mbewe, Kebby Musokotwane, Patrick Musonda, William C Miller, Jeffrey S A Stringer, Benjamin H Chi. 1. *Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL; †Centre for Infectious Disease Research in Zambia, Lusaka, Zambia; ‡Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC; §Institute for Global Health, Vanderbilt University, Nashville, TN; ‖Society for Family Health, Lusaka, Zambia; ¶Zambian Ministry of Community Development and Mother-Child Health, Lusaka, Zambia; #Department of Public Health, University of Zambia School of Medicine, Lusaka, Zambia; **Division of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC; ††Department of Epidemiology, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC; and ‡‡Currently at Departments of Medicine and Pediatrics, Massachusetts General Hospital; Boston, MA.
Abstract
BACKGROUND: In rural settings, HIV-infected pregnant women often live significant distances from facilities that provide prevention of mother-to-child transmission (PMTCT) services. METHODS: We offered universal maternal combination antiretroviral regimens in 4 pilot sites in rural Zambia. To evaluate the impact of services, we conducted a household survey in communities surrounding each facility. We collected information about HIV status and antenatal service utilization from women who delivered in the past 2 years. Using household Global Positioning System coordinates collected in the survey, we measured Euclidean (i.e., straight line) distance between individual households and clinics. Multivariable logistic regression and predicted probabilities were used to determine associations between distance and uptake of PMTCT regimens. RESULTS: From March to December 2011, 390 HIV-infected mothers were surveyed across four communities. Of these, 254 (65%) had household geographical coordinates documented. One hundred sixty-eight women reported use of a PMTCT regimen during pregnancy including 102 who initiated a combination antiretroviral regimen. The probability of PMTCT regimen initiation was the highest within 1.9 km of the facility and gradually declined. Overall, 103 of 145 (71%) who lived within 1.9 km of the facility initiated PMTCT versus 65 of 109 (60%) who lived farther away. For every kilometer increase, the association with PMTCT regimen uptake (adjusted odds ratio: 0.90, 95% confidence interval: 0.82 to 0.99) and combination antiretroviral regimen uptake (adjusted odds ratio: 0.88, 95% confidence interval: 0.80 to 0.97) decreased. CONCLUSIONS: In this rural African setting, uptake of PMTCT regimens was influenced by distance to health facility. Program models that further decentralize care into remote communities are urgently needed.
BACKGROUND: In rural settings, HIV-infected pregnant women often live significant distances from facilities that provide prevention of mother-to-child transmission (PMTCT) services. METHODS: We offered universal maternal combination antiretroviral regimens in 4 pilot sites in rural Zambia. To evaluate the impact of services, we conducted a household survey in communities surrounding each facility. We collected information about HIV status and antenatal service utilization from women who delivered in the past 2 years. Using household Global Positioning System coordinates collected in the survey, we measured Euclidean (i.e., straight line) distance between individual households and clinics. Multivariable logistic regression and predicted probabilities were used to determine associations between distance and uptake of PMTCT regimens. RESULTS: From March to December 2011, 390 HIV-infected mothers were surveyed across four communities. Of these, 254 (65%) had household geographical coordinates documented. One hundred sixty-eight women reported use of a PMTCT regimen during pregnancy including 102 who initiated a combination antiretroviral regimen. The probability of PMTCT regimen initiation was the highest within 1.9 km of the facility and gradually declined. Overall, 103 of 145 (71%) who lived within 1.9 km of the facility initiated PMTCT versus 65 of 109 (60%) who lived farther away. For every kilometer increase, the association with PMTCT regimen uptake (adjusted odds ratio: 0.90, 95% confidence interval: 0.82 to 0.99) and combination antiretroviral regimen uptake (adjusted odds ratio: 0.88, 95% confidence interval: 0.80 to 0.97) decreased. CONCLUSIONS: In this rural African setting, uptake of PMTCT regimens was influenced by distance to health facility. Program models that further decentralize care into remote communities are urgently needed.
Authors: Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst Journal: N Engl J Med Date: 2010-06-17 Impact factor: 91.245
Authors: Benjamin H Chi; Patrick Musonda; Mwila K Lembalemba; Namwinga T Chintu; Matthew G Gartland; Saziso N Mulenga; Maximillian Bweupe; Eleanor Turnbull; Elizabeth M Stringer; Jeffrey S A Stringer Journal: Bull World Health Organ Date: 2014-06-05 Impact factor: 9.408
Authors: Carolina Perez-Heydrich; Jill M Furgurson; Sophia Giebultowicz; Jennifer J Winston; Mohammad Yunus; Peter Kim Streatfield; Michael Emch Journal: Health Place Date: 2012-10-22 Impact factor: 4.078
Authors: Larry W Chang; Stella Alamo; Samuel Guma; Jason Christopher; Tara Suntoke; Richard Omasete; Jennifer P Montis; Thomas C Quinn; Margrethe Juncker; Steven J Reynolds Journal: J Acquir Immune Defic Syndr Date: 2009-03-01 Impact factor: 3.731
Authors: Shabbar Jaffar; Barbara Amuron; Susan Foster; Josephine Birungi; Jonathan Levin; Geoffrey Namara; Christine Nabiryo; Nicaise Ndembi; Rosette Kyomuhangi; Alex Opio; Rebecca Bunnell; Jordan W Tappero; Jonathan Mermin; Alex Coutinho; Heiner Grosskurth Journal: Lancet Date: 2009-11-24 Impact factor: 79.321
Authors: Pamela K Kohler; Adam Akullian; John Okanda; George Otieno; John Kinuthia; Joachim Voss; Brenda Zierler; Grace John-Stewart Journal: J Assoc Nurses AIDS Care Date: 2019 Sep-Oct Impact factor: 1.354
Authors: Catherine Ford; Carla J Chibwesha; Jennifer Winston; Choolwe Jacobs; Mwansa Ketty Lubeya; Patrick Musonda; Jeffrey S A Stringer; Benjamin H Chi Journal: AIDS Care Date: 2017-10-03
Authors: Kelli N O'Laughlin; Dustin J Rabideau; Julius Kasozi; Robert A Parker; Nirma D Bustamante; Zikama M Faustin; Kelsy E Greenwald; Rochelle P Walensky; Ingrid V Bassett Journal: BMC Infect Dis Date: 2016-11-23 Impact factor: 3.090
Authors: Elizabeth A McCarthy; Hamsa L Subramaniam; Margaret L Prust; Marta R Prescott; Felton Mpasela; Albert Mwango; Leah Namonje; Crispin Moyo; Benjamin Chibuye; Jan Willem van den Broek; Lindsey Hehman; Sarah Moberley Journal: PLoS One Date: 2017-04-18 Impact factor: 3.240
Authors: Jane N Mutanga; Simon Mutembo; Amara E Ezeamama; Xiao Song; Robert C Fubisha; Kunda Mutesu-Kapembwa; Derrick Sialondwe; Brenda Simuchembu; Jelita Chinyonga; Philip E Thuma; Christopher C Whalen Journal: BMC Public Health Date: 2019-01-28 Impact factor: 3.295